Products for Research Use Only
RegisterLogin

Research Grade Diridavumab

CAT: 1220-DVV03801Size: 100 μgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1220-DVV03801Size:100 μg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Diridavumab, the alternative names CR6261, is a human monoclonal antibody direct against influenza A hemagglutinin. The CR6261 antibody was first discovered by the Scripps Institute and Crucell, a dutch biopharmaceutical company, and later developed by Janssen Pharmaceutical Companies of Johnson & Johnson under the trade name diridavumab. Cr6261 is under investigation in clinical trial NCT02016066 (A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of Diridavumab in Japanese Healthy Participants) .
Product Name Alternative
CR-6261, CR6261, CAS: 1393659-46-5
Accession Number
P03455
Expression System
Mammalian Cells
Reactivity
Influenza A virus
Applications
Research Grade Biosimilar
Stability
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.
Endotoxin
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Form
Liquid
Buffer
0.01M PBS, pH 7.4.
Notes
For research use only. Not suitable for clinical or therapeutic use.

Related Products

CatalogName
DHD17404Research Grade Tucotuzumab
DHD30405Research Grade Fianlimab
DHB95401Research Grade Emapalumab
DHG52001Research Grade Anetumab
DHC82406Research Grade Posdinemab
DHH02231Research Grade Rulonilimab
DHK07702Research Grade Forimtamig
DHJ92104Research Grade Izuralimab
DHJ70122Research Grade Davoceticept
DHA30606Research Grade Ramatercept

Alternative Products

CatalogName
MBS1564071-01Research Grade Diridavumab
ABS-395-1mgDiridavumab Biosimilar, Research Grade
ICH5481-20mgDiridavumab Biosimilar - Research Grade
PX-TA1349-1000UGDiridavumab Biosimilar - Anti-hemagglutinin HA2 mAb - Research Grade
10-659Diridavumab (influenza A virus hemagglutinin HA2 subunit from various strains) - Research Grade Biosimilar
GTR18118201Diridavumab (influenza A virus hemagglutinin HA2 subunit from various strains) - Research Grade Biosimilar Antibody
GC0057Research Grade
HF943026-01Research Grade Gevokizumab
HY328026-01Research Grade Ziltivekimab
HY328046-01Research Grade Olokizumab

Popular Products